Effect of Ultrasound-Guided Internal Superior Laryngeal Nerve Block on Sore Throat After Intubation by Double-Lumen Bronchial Tube for Thoracoscopic Surgery
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 64
- 试验地点
- 1
- 主要终点
- the pain classification of postoperative sore throat
研究概览
简要总结
investigate the effectiveness and safety of ultrasound-guided bilateral internal branch of the SLN (iSLN) block for alleviating POST immediately after the operation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •ASA 1 to 3
排除标准
- •patients who did not provide consent
- •with a pre-existing sore throat, hoarseness and upper respiratory tract infection
- •tracheal pathology, tracheostomy
- •a history of psychosis, diabetes and thyroid, oral cavity or pharynx surgery
- •known or suspected allergy to ropivacaine
- •chronic opioid use
- •use of nonsteroidal anti-inflammatory drug medication within 24 hours
- •known or suspected difficult airway
- •patients who will be supported by tube ventilator after the operation.
研究组 & 干预措施
experimental group
patients will receive US-guided iSLN block bilaterally with 2 ml of ( 0.5 ml of 2%lidocaine and 1,5 ml of 0.5% bupivacaine) on either side immediate after the operation concomitant with GA in order to undergo thoracoscopic surgery
干预措施: internal superior laryngeal nerve block (Procedure)
experimental group
patients will receive US-guided iSLN block bilaterally with 2 ml of ( 0.5 ml of 2%lidocaine and 1,5 ml of 0.5% bupivacaine) on either side immediate after the operation concomitant with GA in order to undergo thoracoscopic surgery
干预措施: Lidocaine 2% Injectable Solution (Drug)
experimental group
patients will receive US-guided iSLN block bilaterally with 2 ml of ( 0.5 ml of 2%lidocaine and 1,5 ml of 0.5% bupivacaine) on either side immediate after the operation concomitant with GA in order to undergo thoracoscopic surgery
干预措施: Bupivacaine 0.5% Injectable Solution (Drug)
结局指标
主要结局
the pain classification of postoperative sore throat
时间窗: from immediate postoperative till 24 hours postoperative
an established scoring system feom 0 to 4
次要结局
未报告次要终点
研究者
mostafa saieed fahim mansour
lecturer
Menoufia University